Chronos Archive seal
The Human Record

Elvis Presley

Case HR-ML003-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
January 8, 1935 – August 16, 1977
Synthetic DOB
1935-01-08
Index visit
1974-07-10 at age 39
Synthetic MRN
HR-ML003-SYN-TD

Teaching objective: Polypharmacy and prescription opioid and sedative use disorders from several prescribers, in a 39-year-old touring singer who comes in for fatigue, weight gain, constipation, sleepiness and high blood pressure. The episode covers a brown-bag medication reconciliation and prescription drug monitoring program review that finds two opioids, two benzodiazepines and an appetite suppressant from five prescribers; a nonjudgmental DSM-5-TR assessment; naloxone at the first visit; a single-prescriber agreement; buprenorphine started in the office under the ASAM 1968 guideline, with the guideline's advice that taking a benzodiazepine is not a reason to withhold it; the benzodiazepines combined into diazepam and tapered slowly under the 1973 joint guideline; a structured safety assessment with means safety and the 988 Suicide & Crisis Lifeline; hypertension confirmed with home readings and treated under the 1973 AHA/ACC guideline; obesity treated without stigma with tirzepatide, which also treats obstructive sleep apnea; STOP-Bang and in-laboratory polysomnography because opioids make home testing unreliable; opioid-induced constipation; glaucoma that rules out phentermine and anticholinergic sleep aids; acute back pain managed on buprenorphine; and care planned around a performing and touring schedule.

Historical timeline

DateEventClaims
January 8, 1935Born in Tupelo, Mississippi.CLM-0001
1953First recording; national fame from 1956; Army service from 1958 to 1960; Las Vegas engagements and tours in the 1970s. Believed never to have smoked or drunk alcohol.CLM-0002, CLM-0011
1971Acute angle-closure glaucoma; under an ophthalmologist's care from then on.CLM-0007
October 15, 1973Hospital stay in Memphis under an assumed name; later testimony says he was withdrawn from narcotic drugs.CLM-0003
July 1974A few weeks off at Graceland after a year of engagements and tours.CLM-0002
August 19, 1974Las Vegas engagement, then a tour from September 27 to October 14.CLM-0015
January 28, 1975Two hospital stays in 1975, for abdominal problems and swelling and then for breathlessness and swelling; reported treatment for hypertension and a blocked, enlarged colon.CLM-0004, CLM-0005
1975 to 1977About 19,000 doses of stimulants, sedatives and painkillers prescribed by one physician in his last 30 months, with drugs also from other sources.CLM-0009
August 16, 1977Dies at Graceland at 42; the cause is disputed. Overweight in his last years; his glaucoma is later interpreted as steroid-induced.CLM-0012, CLM-0013, CLM-0014, CLM-0006, CLM-0008
November 4, 1981His physician is acquitted of overprescribing after testimony that he was addicted to prescribed drugs.CLM-0010

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Elvis Aron Presley was born in a two-room house in Tupelo, Mississippi, on January 8, 1935; his family moved to Memphis when he was 13. confirmed Ivins M. Elvis Presley Dies; Rock Singer Was 42. The New York Times, August 17, 1977 (On This Day archive) supports
HISTMED Master Roster v3 context
D He made his first record in 1953, became a national star in 1956, served in the Army in West Germany from 1958 to 1960, and by the 1970s performed long engagements in Las Vegas and toured constantly. In 1974 he played Las Vegas from January 26 to February 9, toured through much of March, including four shows in Memphis on March 16 and 17 and a recorded show there on March 20, played Lake Tahoe from May 16 to 26, toured again in mid-June, and took a few weeks off at Graceland from early July.
Anchors the performing and touring schedule in the modern social history and the timing of the index visit.
confirmed Ivins M. Elvis Presley Dies; Rock Singer Was 42. The New York Times, August 17, 1977 (On This Day archive) supports
Elvis History: 1974-1977 supports
D From October 15 to November 1, 1973, he was treated at Baptist Memorial Hospital in Memphis under an assumed name; at the 1981 trial of his physician, an internal medicine specialist who reviewed the records testified that the consulting physicians were "withdrawing him from narcotic drugs."
The anchor for the synthetic opioid use disorder; recorded as trial testimony reported by a wire service.
confirmed Elvis Presley was a drug addict and was hospitalized (UPI, October 23, 1981) supports
D He was treated at Baptist Hospital again from January 28 to February 13, 1975, when the admission note recorded abdominal problems and swelling of the face, hands and legs, and from August 21 to September 25, 1975, for shortness of breath and swelling. In 1977 the medical examiner said that the drugs he found were those prescribed for hypertension and a blockage of the colon, for which Presley had been hospitalized twice in 1975.
History after the index visit; anchors the synthetic hypertension and constipation.
confirmed Elvis Presley was a drug addict and was hospitalized (UPI, October 23, 1981) supports
Ivins M. Elvis Presley Dies; Rock Singer Was 42. The New York Times, August 17, 1977 (On This Day archive) supports
HISTMED Master Roster v3 context
D In 1977 an unnamed Baptist Hospital employee told Rolling Stone that he had been treated there for "hypertension, enlarged colon, gastroenteritis, stomach inflammation," had "a severe liver condition," had received cortisone, and weighed at least 230 pounds; the hospital's doctors discounted a suggestion of lupus.
An anonymous contemporary report; recorded as history only and not used for any modern diagnosis beyond the synthetic liver tests.
probable Flippo C. Elvis Presley: Funeral in Memphis. Rolling Stone, 1977 supports
D He was about six feet tall and had once weighed about 175 pounds; in his last years he was reported to be overweight and at times appeared bloated on stage.
Anchors the synthetic weight gain and obesity, which the modern episode treats without stigma.
confirmed Ivins M. Elvis Presley Dies; Rock Singer Was 42. The New York Times, August 17, 1977 (On This Day archive) supports
HISTMED Master Roster v3 context
D He had glaucoma, including an episode of acute angle-closure glaucoma in 1971, and was under the care of one ophthalmologist from 1971 on.
Anchors the synthetic glaucoma and the ophthalmology follow-up.
confirmed Zegers RH, Liu KC, Heutink J, Tennant F, Weinreb RN. Suspicious eyes - Elvis's glaucoma battle. J Med Biogr 2025;33(2):112-115 (PMID 39150457) supports
HISTMED Master Roster v3 context
R A 2025 ophthalmology review interprets his glaucoma as steroid-induced, from lifelong use of steroids both prescribed and self-administered, with secondary angle closure most likely due to anterior uveitis.
Retrospective interpretation; the modern diagnosis of glaucoma secondary to drugs is synthetic.
probable Zegers RH, Liu KC, Heutink J, Tennant F, Weinreb RN. Suspicious eyes - Elvis's glaucoma battle. J Med Biogr 2025;33(2):112-115 (PMID 39150457) supports
D At the 1981 trial of his physician, George Nichopoulos, prosecutors showed that the physician had prescribed about 19,000 doses of stimulants, sedatives and painkillers for him in the last 30 months of his life, including 1,679 addictive pills in 205 days between the two 1975 hospital stays; the defense argued that he obtained drugs from many other sources, including amphetamines mailed from the West Coast, and a detective testified to collecting prescriptions from 140 Memphis pharmacies.
Documented history of prescribed controlled drugs from several sources; anchors the synthetic multiple-prescriber history, the prescription drug monitoring program review and the single-prescriber agreement. No decision or statement in the modern episode is attributed to any real person.
confirmed Murphy P. Details of Presley's death still unknown (UPI, November 7, 1981) supports
Elvis Presley was a drug addict and was hospitalized (UPI, October 23, 1981) supports
Elvis Presley was a drug addict and received 'staggering' amounts of drugs (UPI, October 13, 1981) supports
HISTMED Master Roster v3 context
D Testimony at the trial described him as addicted to prescribed stimulants, sedatives and painkillers; the internal medicine specialist testified, "Absolutely. He was addicted." On November 4, 1981, the jury acquitted the physician of overprescribing, citing his efforts to substitute placebos and intercept drugs sent from elsewhere; the physician then said that drugs "may have played a part" in the death.
History after the modern episode; recorded without blame and without a modern statement attributed to any real person.
confirmed Elvis Presley was a drug addict and was hospitalized (UPI, October 23, 1981) supports
Murphy P. Details of Presley's death still unknown (UPI, November 7, 1981) supports
Thorsberg F. Jurors say Elvis doctor operated in good faith (UPI, November 5, 1981) supports
D It was believed that he neither smoked nor drank alcohol.
Anchors the synthetic alcohol and tobacco history.
probable Ivins M. Elvis Presley Dies; Rock Singer Was 42. The New York Times, August 17, 1977 (On This Day archive) supports
D On August 16, 1977, at 42, he was found unresponsive on the floor of his bathroom at Graceland, his home in Memphis, and was pronounced dead at Baptist Memorial Hospital.
History only, recorded in one plain sentence.
confirmed Ivins M. Elvis Presley Dies; Rock Singer Was 42. The New York Times, August 17, 1977 (On This Day archive) supports
Wakeman G. How Did Elvis Presley Die? supports
Elvis History: 1974-1977 supports
HISTMED Master Roster v3 context
R The cause of his death is disputed. The medical examiner gave cardiac arrhythmia, citing a history of mild hypertension and evidence of coronary artery disease, and later ruled it heart disease; the autopsy report was never released. Trial testimony said that 14 drugs, including codeine at ten times the maximum accepted level, were found in tissue samples, and later accounts attribute the death to multiple prescription drugs, to heart disease, or to straining with a severely enlarged colon.
History only; no cause of death is assumed in the modern episode.
disputed Ivins M. Elvis Presley Dies; Rock Singer Was 42. The New York Times, August 17, 1977 (On This Day archive) supports
Elvis Presley was a drug addict and was hospitalized (UPI, October 23, 1981) supports
Murphy P. Details of Presley's death still unknown (UPI, November 7, 1981) supports
Wakeman G. How Did Elvis Presley Die? supports
HISTMED Master Roster v3 context
R His physician later said that he had a severe form of megacolon, his colon about twice its normal diameter and impacted with stool at his death.
Reported second-hand in a 2026 article quoting a biographer; recorded as a possibility only.
possible Wakeman G. How Did Elvis Presley Die? supports
HISTMED Master Roster v3 context
D After the weeks off in July 1974 he played the Las Vegas Hilton from August 19 to September 2, talking on stage about karate, and toured from September 27 to October 14, ending at Lake Tahoe on October 11 to 14.
History after the index visit; the modern episode plans care around the same engagements.
confirmed Elvis History: 1974-1977 supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Fatigue, weight gain of about 14 kg in two years, constipation with a bowel movement every five to seven days, loud snoring with daytime sleepiness, and high blood pressure readings, in a man taking two opioids, two benzodiazepines and an appetite suppressant from five prescribers; under evaluation with addiction medicine, a sleep study and home blood pressure readings resolved confirmed active CLM-0003, CLM-0009, CLM-0010, CLM-0006
S Obesity, class 1 (BMI 32.5), with prediabetes (hemoglobin A1c 5.8%); recorded without stigma; weight gain began with long touring schedules, night eating after shows and an appetite suppressant that stopped working active confirmed both_with_link CLM-0006
S Glaucoma secondary to steroids, both eyes, mild stage, after an acute angle-closure episode treated years ago; intraocular pressure controlled on latanoprost under his ophthalmologist; anticholinergic and sympathomimetic drugs to be avoided active confirmed both_with_link CLM-0007, CLM-0008
S Opioid use disorder, severe, with prescription opioids from more than one prescriber (seven DSM-5-TR criteria, tolerance and withdrawal counted because the opioids were not taken as prescribed); on buprenorphine from the consultation; synthetic modern episode linked to his documented withdrawal from narcotic drugs and prescribed painkillers active confirmed both_with_link CLM-0003, CLM-0009, CLM-0010
S Sedative, hypnotic, or anxiolytic use disorder (benzodiazepines), moderate (five DSM-5-TR criteria), with two benzodiazepines from two prescribers; combined into diazepam and tapering slowly; synthetic modern episode linked to his documented prescribed sedatives active confirmed both_with_link CLM-0003, CLM-0009, CLM-0010
S Hypertension, stage 2, confirmed by a home average of 146/94 a week after stopping phentermine; ECG and urine albumin normal active confirmed both_with_link CLM-0004
S Obstructive sleep apnea, moderate (apnea-hypopnea index 26 an hour, central apnea index 4, oxygen nadir 80% on in-laboratory polysomnography), worsened by opioids and benzodiazepines; on CPAP active confirmed active
S Opioid-induced constipation (Rome IV), improving after the change to buprenorphine; no alarm features active confirmed both_with_link CLM-0004, CLM-0014
S Acute low back strain after karate practice, without radicular signs or red flags, in a man on buprenorphine; resolved resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 1974-07-10 Hemoglobin [Mass/volume] in Blood 15.1 g/dL
Reference 13.2-17.1 g/dL
http://loinc.org · 718-7
S 1974-07-10 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1974-07-10 Potassium [Moles/volume] in Serum or Plasma 4 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1974-07-10 Creatinine [Mass/volume] in Serum or Plasma 1 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1974-07-10 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1969)/1.73 sq M 98 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1974-07-10 Glucose [Mass/volume] in Serum or Plasma 104 mg/dL (high)
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1974-07-10 Hemoglobin A1c/Hemoglobin.total in Blood 5.8% (high)
Reference <=5.6%
http://loinc.org · 4548-4
S 1974-07-10 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 72 U/L (high)
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1974-07-10 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 52 U/L (high)
Reference 8-48 U/L
http://loinc.org · 1920-8
S 1974-07-10 Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 78 U/L (high)
Reference 8-61 U/L
http://loinc.org · 2324-2
S 1974-07-10 Thyrotropin [Units/volume] in Serum or Plasma 2.1 mIU/L
Reference 0.4-4.5 mIU/L
http://loinc.org · 3016-3
S 1974-07-10 Albumin/Creatinine [Mass Ratio] in Urine 14 mg/g{creat}
Reference <=29 mg/g{creat}
http://loinc.org · 9318-7
S 1974-07-10 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 8 http://loinc.org · 44261-6
S 1974-07-10 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 9 http://loinc.org · 70274-6
S 1974-07-10 Total score [DAST-10] 7 http://loinc.org · 82667-7
S 1974-07-10 Total score [AUDIT-C] 0 http://loinc.org · 75626-2
S 1974-08-14 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 5 http://loinc.org · 44261-6
S 1974-08-14 Cholesterol [Mass/volume] in Serum or Plasma 214 mg/dL (high)
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 1974-08-14 Cholesterol in HDL [Mass/volume] in Serum or Plasma 38 mg/dL (low)
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 1974-08-14 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 140 mg/dL (high)
Reference <=129 mg/dL
http://loinc.org · 13457-7
S 1974-08-14 Triglyceride [Mass/volume] in Serum or Plasma 180 mg/dL (high)
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 1974-08-07 Potassium [Moles/volume] in Serum or Plasma 4.4 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1974-08-07 Creatinine [Mass/volume] in Serum or Plasma 1.04 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1974-08-07 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1969)/1.73 sq M 94 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1974-08-07 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 http://loinc.org · 44261-6
S 1974-08-07 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 8 http://loinc.org · 70274-6
S 1974-09-23 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 5 http://loinc.org · 44261-6
S 1974-09-23 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 7 http://loinc.org · 70274-6
S 1974-10-28 Potassium [Moles/volume] in Serum or Plasma 4.3 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1974-10-28 Creatinine [Mass/volume] in Serum or Plasma 1.02 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1974-10-28 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1969)/1.73 sq M 96 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1974-10-28 Hemoglobin A1c/Hemoglobin.total in Blood 5.5%
Reference <=5.6%
http://loinc.org · 4548-4
S 1974-10-28 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 44 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1974-10-28 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 33 U/L
Reference 8-48 U/L
http://loinc.org · 1920-8
S 1974-10-28 Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 55 U/L
Reference 8-61 U/L
http://loinc.org · 2324-2
S 1974-10-28 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 http://loinc.org · 44261-6
S 1974-10-28 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 5 http://loinc.org · 70274-6

Synthetic vital signs

DateMeasureResultLOINCGrade
1974-07-10Body height183 cm8302-2S
1974-07-10Body weight109 kg29463-7S
1974-07-10Body mass index (BMI) [Ratio]32.5 kg/m239156-5S
1974-07-10Systolic blood pressure154 mm[Hg]8480-6S
1974-07-10Diastolic blood pressure98 mm[Hg]8462-4S
1974-07-10Heart rate94 /min8867-4S
1974-07-10Respiratory rate16 /min9279-1S
1974-07-10Body temperature36.8 Cel8310-5S
1974-07-10Oxygen saturation in Arterial blood by Pulse oximetry96 %59408-5S
1974-07-17Body height183 cm8302-2S
1974-07-17Body weight108.6 kg29463-7S
1974-07-17Body mass index (BMI) [Ratio]32.4 kg/m239156-5S
1974-07-17Systolic blood pressure146 mm[Hg]8480-6S
1974-07-17Diastolic blood pressure94 mm[Hg]8462-4S
1974-07-17Heart rate102 /min8867-4S
1974-07-17Respiratory rate18 /min9279-1S
1974-07-17Body temperature37 Cel8310-5S
1974-07-17Oxygen saturation in Arterial blood by Pulse oximetry96 %59408-5S
1974-08-07Body height183 cm8302-2S
1974-08-07Body weight108.2 kg29463-7S
1974-08-07Body mass index (BMI) [Ratio]32.3 kg/m239156-5S
1974-08-07Systolic blood pressure128 mm[Hg]8480-6S
1974-08-07Diastolic blood pressure82 mm[Hg]8462-4S
1974-08-07Heart rate76 /min8867-4S
1974-08-07Respiratory rate14 /min9279-1S
1974-08-07Body temperature36.7 Cel8310-5S
1974-08-07Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1974-09-23Body height183 cm8302-2S
1974-09-23Body weight105.1 kg29463-7S
1974-09-23Body mass index (BMI) [Ratio]31.4 kg/m239156-5S
1974-09-23Systolic blood pressure126 mm[Hg]8480-6S
1974-09-23Diastolic blood pressure80 mm[Hg]8462-4S
1974-09-23Heart rate74 /min8867-4S
1974-09-23Respiratory rate14 /min9279-1S
1974-09-23Body temperature36.6 Cel8310-5S
1974-09-23Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1974-10-28Body height183 cm8302-2S
1974-10-28Body weight102.6 kg29463-7S
1974-10-28Body mass index (BMI) [Ratio]30.6 kg/m239156-5S
1974-10-28Systolic blood pressure122 mm[Hg]8480-6S
1974-10-28Diastolic blood pressure78 mm[Hg]8462-4S
1974-10-28Heart rate70 /min8867-4S
1974-10-28Respiratory rate14 /min9279-1S
1974-10-28Body temperature36.6 Cel8310-5S
1974-10-28Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1974-08-14Body height183 cm8302-2S
1974-08-14Body weight107.6 kg29463-7S
1974-08-14Body mass index (BMI) [Ratio]32.1 kg/m239156-5S
1974-08-14Systolic blood pressure126 mm[Hg]8480-6S
1974-08-14Diastolic blood pressure80 mm[Hg]8462-4S
1974-08-14Heart rate74 /min8867-4S
1974-08-14Respiratory rate14 /min9279-1S
1974-08-14Body temperature36.6 Cel8310-5S
1974-08-14Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1974-09-09Body height183 cm8302-2S
1974-09-09Body weight106 kg29463-7S
1974-09-09Body mass index (BMI) [Ratio]31.7 kg/m239156-5S
1974-09-09Systolic blood pressure134 mm[Hg]8480-6S
1974-09-09Diastolic blood pressure84 mm[Hg]8462-4S
1974-09-09Heart rate84 /min8867-4S
1974-09-09Respiratory rate16 /min9279-1S
1974-09-09Body temperature36.7 Cel8310-5S
1974-09-09Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Structured safety assessment

Current ideation
absent
Intent
absent
Plan
absent
Disposition
Outpatient care with close follow-up. No current or past suicidal ideation. Risk factors reviewed: opioid and sedative use disorders under assessment, taking opioids with benzodiazepines, sleep apnea symptoms, firearms at home, and the stress of touring. Means safety: firearms to be stored locked and unloaded with ammunition separate; all controlled medicines in a locked box, with unused tablets from earlier prescriptions taken back to a pharmacy; seven-day supplies; naloxone at home and in the tour bag, with two people around him taught to use it. A written safety plan was made with him, and the 988 Suicide & Crisis Lifeline (call or text 988) was saved in his phone. Safety is reviewed at every visit

This assessment is synthetic and does not convert historical behavior into a present-day fact.

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
Stop full-agonist opioids and stabilize on buprenorphine without significant withdrawal1974-08-07completedBuprenorphine 16 mg a day since the consultation; no withdrawal after the first day; cravings low
One prescriber and one pharmacy for all controlled medicines1974-09-23completedMonitoring program shows only this clinic's prescriptions since intake
Lower the diazepam dose slowly, 5 to 10% every two to four weeks, toward stopping1974-10-28active40 mg a day after the alprazolam was combined into it, to 30 mg at four months; no withdrawal symptoms; taper continuing
Home blood pressure below 130/801974-08-07completedHome average 146/94 to 126/80 on amlodipine and valsartan
Lose 5% or more of body weight1974-10-28completed109.0 to 102.6 kg (5.9%) on tirzepatide, with more activity and earlier meals
CPAP on at least 70% of nights for four hours or more, with less daytime sleepiness1974-10-28completedCPAP on 88% of nights; Epworth 14 to 6
A bowel movement at least every two days without straining1974-08-07completedEvery one to two days on buprenorphine and polyethylene glycol

Interventions

InterventionStatusGuideline
Safe prescribing of controlled drugs: a brown-bag reconciliation of every medicine, a prescription drug monitoring program check before every controlled prescription, a written single-prescriber agreement with one pharmacy, urine drug testing explained as part of care, seven-day supplies at first, a locked box, and take-back of unused tablets; no controlled drug stopped abruptlycompletedGL-CDC-OPIOID-2022, GL-CDC-PDMP, GL-BZD-TAPER-2025
Addiction medicine consultation to make the substance use diagnoses, start medication for opioid use disorder, and plan the benzodiazepine change and tapercompletedGL-ASAM-OUD-2020, GL-BZD-TAPER-2025
Overdose prevention: naloxone nasal spray at home and in the tour bag, two people around him taught to use it, no alcohol or other sedatives, and the danger of opioids with benzodiazepines and with the sleep apnea that is suspected explainedcompletedGL-CDC-OPIOID-2022, GL-ASAM-OUD-2020
Safety: a structured safety assessment, a written safety plan, firearms locked and unloaded with ammunition separate, the 988 Suicide & Crisis Lifeline, and safety review at every visit; PHQ-9 and GAD-7 at each reviewcompletedGL-SUICIDE-2024, GL-USPSTF-DEP-2023, GL-CMID-2026
Buprenorphine for opioid use disorder: buprenorphine with naloxone started in the office at a COWS score above 8, 16 mg a day, weekly contact for the first month, prescriptions from this clinic only, counseling, and no tapering off while he is doing well; buprenorphine is not withheld because he takes a benzodiazepinecompletedGL-ASAM-OUD-2020, GL-CDC-OPIOID-2022
Benzodiazepine change and taper: alprazolam combined into diazepam (40 mg a day), held steady until buprenorphine is stable, then reduced by about 5 to 10% every two to four weeks, paused during engagements, illness or withdrawal symptoms, never stopped abruptly; CBT for anxiety and insomnia alongside; no Z-drug or other sedative in its placecompletedGL-BZD-TAPER-2025
Hypertension: home readings confirmed stage 2 hypertension, so two first-line drugs were started in one pill (amlodipine with valsartan), with potassium and creatinine two to four weeks later, a target below 130/80, sodium reduction, activity and weight losscompletedGL-AHA-HTN-2025, GL-CMID-2026
Obstructive sleep apnea: CPAP from the split-night titration, with adherence data reviewed at each visit and a travel machine for tours; no sedative added at nightcompletedGL-AASM-PAP-2019, GL-AASM-DX-2017
Weight treated without stigma: earlier meals, protein and fiber, more walking and karate between tours, and tirzepatide once weekly, chosen because it also treats obstructive sleep apnea with obesity, raised slowly with a watch on nausea and constipationcompletedGL-AGA-OBESITY-2022, GL-SURMOUNT-OSA-2024
Constipation on opioids: polyethylene glycol daily with senna as needed, fluids and fiber; a peripherally acting opioid antagonist only if these fail; an abdominal radiograph only for pain, distension or vomitingcompletedGL-AGA-OIC-2019, GL-AGA-ACG-CIC-2023
Glaucoma: latanoprost continued, his ophthalmologist kept informed of every new medicine, no phentermine, decongestant or anticholinergic sleep aid, steroids only when essential and with his ophthalmologist's knowledge, and urgent care for eye pain with haloscompletedGL-AAO-POAG-2020, GL-CMID-2026
Performing and touring: no medication change in the week before an engagement, weekly video visits while away, controlled prescriptions sent only to one named pharmacy, a written plan for missed doses, naloxone and any prescribed devices in the tour bag, and a letter he controls for venuescompletedGL-ASAM-OUD-2020, GL-BZD-TAPER-2025

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Ivins M. Elvis Presley Dies; Rock Singer Was 42. The New York Times, August 17, 1977 (On This Day archive) The New York Times other
SRC-0002 Elvis History: 1974-1977 Elvis Presley's Graceland (Elvis Presley Enterprises) other
SRC-0003 Elvis Presley was a drug addict and was hospitalized (UPI, October 23, 1981) United Press International other
SRC-0004 Flippo C. Elvis Presley: Funeral in Memphis. Rolling Stone, 1977 Rolling Stone other
SRC-0005 Zegers RH, Liu KC, Heutink J, Tennant F, Weinreb RN. Suspicious eyes - Elvis's glaucoma battle. J Med Biogr 2025;33(2):112-115 (PMID 39150457) Journal of Medical Biography scholarly
SRC-0006 Murphy P. Details of Presley's death still unknown (UPI, November 7, 1981) United Press International other
SRC-0007 Elvis Presley was a drug addict and received 'staggering' amounts of drugs (UPI, October 13, 1981) United Press International other
SRC-0008 Thorsberg F. Jurors say Elvis doctor operated in good faith (UPI, November 5, 1981) United Press International other
SRC-0009 HISTMED Master Roster v3 The Human Record project other
SRC-0010 Wakeman G. How Did Elvis Presley Die? HISTORY (A&E Television Networks) other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the DSM-5-TR criteria counts (tolerance and withdrawal counted because use was not as prescribed), the MME totals, the one-week delay before buprenorphine at his choice with naloxone and seven-day supplies in between, the in-office induction, buprenorphine with a benzodiazepine, the alprazolam to diazepam conversion and the taper pace, amlodipine with valsartan as a single pill for stage 2 hypertension, tirzepatide for obesity with obstructive sleep apnea while on buprenorphine, in-laboratory polysomnography on opioids, stopping phentermine for glaucoma and blood pressure, and acute back pain treated by splitting the buprenorphine dose with naproxen.
provenance reviewnot_startedSources: The New York Times obituary (1977), Graceland's official timeline, four UPI wire reports of the 1981 trial, the 1977 Rolling Stone report, a HISTORY article (2026), and the PubMed abstract of Zegers et al. (2025). The Commercial Appeal could not be reached and the biographies were not read. The cause of death is graded R and disputed; the steroid explanation of his glaucoma is R, probable; the megacolon account is R, possible.
safe messaging reviewnot_startedDrug and mental-health claims are marked sensitive; the 1973 hospital stay and the trial testimony are recorded without detail beyond the reports; his death is recorded in one plain sentence and its disputed cause separately; person-first language; weight is described without stigma; the safety assessment gives the 988 Suicide & Crisis Lifeline and addresses means safety, including firearms. His physician appears only in documented history, with no modern decision or statement attributed to him; no living person is named, and nothing is attributed to his former wife or his daughter.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.